¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Fractional Flow Reserve, Myocardial"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • myocardial infarction
    ½É±Ù°æ»öÁõ
  • myocardial irritability
    ½É±Ù°ú¹Î¼º, ½É±ÙÀÚ±ØÈïºÐ¼º
  • myocardial ischemia
    ½É±ÙÇãÇ÷, ½ÉÀå±ÙÀ°ÇãÇ÷
  • myocardial lead
    ½É±ÙÀ¯µµ, ½ÉÀå±ÙÀ°À¯µµ
  • myocardial perfusion scintigraphy
    ½É±Ù°ü·ù¼¶±¤Á¶¿µ(¼ú)
  • myocardial scan
    ½É±Ù½ºÄµ
  • post-myocardial infarction syndrome
    ½É±Ù°æ»öÈÄÁõÈıº
  • septal myocardial infarction
    Á߰ݽɱٰæ»öÁõ, »çÀ̸·½É±Ù°æ»öÁõ
  • silent myocardial infarction
    ¹«Áõ»ó½É±Ù°æ»öÁõ
  • alkaline reserve
    1. ¾ËÄ®¸®¿¹ºñ 2. ¾ËÄ®¸®¿¹ºñ·Â
  • breathing reserve
    1. È£Èí¿¹ºñ 2. ȯ±â¿¹ºñ·® 3. È£Èí¿¹ºñ·Â
  • breathing reserve ratio
    ȯ±â¿¹ºñºñ
  • coronary reserve
    °ü»óµ¿¸Æ¿¹ºñ·Â, ½ÉÀ嵿¸Æ¿¹ºñ·Â
  • diastolic reserve
    È®Àå±â¿¹ºñ·Â
  • expiratory reserve volume
    ³¯¼û¿¹ºñ·®, È£±â¿¹ºñ·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • septal myocardial infarction
    Á߰ݽɱٰæ»öÁõ
  • silent myocardial infarction
    ¹«Áõ»ó½É±Ù°æ»öÁõ
  • transmural myocardial infarction
    ÀüÃþ½É±Ù°æ»öÁõ
  • myocardial lead
    ½É±ÙÀ¯µµ
  • myocardial
    ½ÉÀå±ÙÀ°-, ½É±Ù-
  • myocardial scan
    ½ÉÀå±ÙÀ°½ºÄµ
  • myocardial siderosis
    ½ÉÀå±ÙÀ°Ã¶Ä§ÂøÁõ
  • myocardial stimulant
    ½É±ÙÀÚ±ØÁ¦, °­½ÉÁ¦
  • myocardial perfusion scintigraphy
    ½É±ÙÁÖ»ç¼ú, ½ÉÀå±ÙÀ°¼¶±¤Á¶¿µ¼ú
  • alkaline reserve
    ¾ËÄ®¸®¿¹ºñ·Â
  • breathing reserve
    È£Èí¿¹ºñ, ȯ±â¿¹ºñ·®, È£Èí¿¹ºñ·Â
  • breathing reserve ratio
    ȯ±â¿¹ºñºñ
  • reserve blood
    ¿¹ºñÇ÷·®
  • coronary reserve
    ½ÉÀ嵿¸Æ¿¹ºñ·Â, °ü»óµ¿¸Æ¿¹ºñ·Â
  • reserve cell
    ¿¹ºñ¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fractional concentration
    ºÐȹ³óµµ.
  • fractional dose
    ºÐÇÒ·®.
  • fractional echo imaging
    ºÐÇÒ ¿¡ÄÚ ¿µ»ó
  • fractional extraction
    ºÐȹÃßÃâ(¡­õÎõó).
  • fractional fibrinogen catabolic rate
    ºÐȹº° ¼¶À¯¼Ò¿ø ´ë»çÀ².
  • fractional neutralization
    ºÐȹÁßÈ­.
  • fractional sodium excretion
    ºÐȹ¼º³ªÆ®·ý¹è¼³
  • fractional sterilization
    ºÐÇÒ¸ê±Õ.
  • fractional sterilization
    ºÐÇÒ¸ê±Õ.
  • ELBF=£¾effective liver blood flow
    À¯È¿¼º °£Ç÷·ù.
  • ELBF=£¾effective liver blood flow
    À¯È¿ °£Ç÷·ù.
  • ERPF => effective renal plasma flow
    À¯È¿½ÅÇ÷ÀåÀ¯Åë·®
  • ERPF=£¾effective renal plasma flow
    À¯È¿½ÅÇ÷·ù·®.
  • Flow
    À¯·®(êüÕá), È帧
  • Flow-limited exchange
    À¯·®Á¦Çѱ³È¯(ð¤ùÚÎßüµ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • breathing reserve =BR
    È£Èí¿¹ºñ.³»°úȯ±â¿¹ºñ·®(üµÑ¨çãÝáåÖ).¸¶ÃëÈ£Èí¿¹ºñ·Â.
  • breathing reserve ratio
    ȯ±â¿¹ºñºñ(¡­çãÝáÝï).
  • cardiac reserve
    ½É(Àå)¿¹ºñ·Â(ãýíôçãÝáæ³).
  • cardiac reserve
    ½É(Àå)¿¹ºñ·Â (¡­çãÝáæ³).
  • complementary air =inspiratory reserve volume
    ¿¹ºñÈí±â·®(çãÝáýåѨåÖ) .
  • coronary reserve
    °ü(»ó)¿¹ºñ·Â(ήßÒçãÝáæ³).
  • coronary reserve
    °ü(»ó)¿¹ºñ·Â(ήßÒçãÝáæ³).
  • diastolic reserve
    È®Àå±âº¸À¯·®.
  • expiratory reserve volume =ERV
    È£½Ä¼º ¿¹ºñ¿ëÀû(û¼ãÓàõçãÝáé»îÝ). ¸¶ Ãë È£±â¿¹ºñ·®, ¿¹ºñÈ£±â
  • expiratory reserve volume =ERV
    È£±â¿¹ºñ·®, ¿¹ºñÈ£±â·®, È£½Ä¼º ¿¹ºñ¿ëÀû
  • fusional reserve
    À¶ÇÕ¿©ºÐ
  • inspiratory reserve volume
    Èí½Ä(¼º)¿¹ºñ¿ëÀû(ýåãÓàõçãÝáé»îÝ), Èí±âÀܱⷮ( ¡­íÑѨåÖ).
  • oxygen reserve
    »ê¼Ò¿¹ºñ
  • oxygen reserve
    »ê¼Ò¿¹ºñ(ß«áÈçãÝá).
  • pituitary reserve
    ³úÇϼöü¿¹ºñ·Â<--¿©·®(æ®Õá)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • double refraction of flow
    À¯µ¿º¹±¼Àý(×µÔÑÜÜÏÝï¹) (ÔÒ) flow birefringence
  • field flow fractionation
    Àå(íÞ)È帧 ºÐȹ¹ý(ÝÂüñÛö)
  • flow birefringence
    È帧 º¹±¼Àý(ÜÜÏÝï¹)
  • flow cell
    È帧 ½Ç(ãø)
  • flow dichroism
    È帧 ÀÌ»ö¼º(ì£ßäàõ)
  • flow method
    È긲¹ý(Ûö)
  • flow quenching
    È帧 ¼Ò±¤(á¼ÎÃ)
  • gas-flow counter
    °³½º È긲 °èÃø±â(ͪö´Ðï)
  • gradient-flow method
    ±¸¹è(ÎþÛÕ)-È帧¹ý(Ûö)
  • laminar flow
    Ãþ·ù(öµ×µ)
  • pulsatile flow
    ¸Æ·ù(Øæ×µ)
  • rapid flow kinetics
    ±Þ·ù¿ªµ¿ÇÐ(Ðá×µæ³ÔÑùÊ)
  • rapid flow technique
    ±Þ·ù¼ú(Ðá×µâú)
  • sedimentation field flow fractionation
    ħ°­Àå(öØË½íÞ) È帧ºÐȹ¹ý(ÝÂüñÛö)
  • stopped flow technique
    È帧Á¤Áö ¼ú(ïÎò­âú)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • color Doppler flow mapping
    »öµµÇ÷¯Ç÷·ùÁöµµÈ­
  • color flow imaging
    »öÇ÷·ù¿µ»ó
  • color flow mapping
    »öÇ÷·ùÁöµµÈ­
  • counter current flow
    ¿ªÈ帧, °Å²Ù·ÎÈ帧, ¿ª·ù
  • flow
    ±â·ù, À¯·®, È帧
  • flow artifact
    À¯µ¿Àΰø¹°
  • flow chart
    È帧µµ, ¼ø¼­µµ
  • flow compensated pulse sequence
    À¯µ¿º¸»óÆÞ½º¿¬¼â
  • flow compensation
    À¯µ¿º¸»ó
  • flow compensation gradient technique
    À¯µ¿º¸»ó°æ»ç±â¹ý
  • flow cytometry
    À¯¼Ó¼¼Æ÷ºÐ¼®¹ý
  • flow encoding axis
    À¯µ¿ºÎȣȭÃà
  • flow misregistration
    À¯µ¿¿Àµî·Ï
  • flow phenomena
    À¯µ¿Çö»ó
  • flow related enhancement
    À¯µ¿°ü·ÃÁõ°­
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
AMI acquired monosaccharide intolerance; acute myocardial infarction; amitriptyline; anterior myocardial...
IMI immunologically measurable insulin; impending myocardial infarction; Imperial Mycological Institute ...
MD Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major...
MI first meiotic metaphase; maturation index; medical illustrator; medical informatics; medical inspect...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CVR Cerebrovascular reserve
ERV Expiratory Reserve Volume
RFR Renal functional reserve
WR Western Reserve
HRR heart rate reserve
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myocardial infarction
    ½É±Ù °æ»öÁõ, ½É±Ù °æ»ö
    1. °ü»óµ¿¸ÆÀ¸·ÎºÎÅÍÀÇ Ç÷·ù°¡ µÎÀýµÇ°í ½É±ÙÀÇ ÀϺΰ¡ »ê¼Ò °áÇÌÀ¸·Î ÀÎÇØ ±«»ç¿¡ ºüÁø °ÍÀ» ¸»ÇÑ´Ù. ±«»çÀÇ ¹üÀ§¿¡ µû¶ó¼­ ¿¹ÈÄ´Â ´Ù¸¥µ¥ ÀϹÝÀûÀ¸·Î Ä¡¸í·üÀÌ ³ôÀº ÁßÁõÀÇ ÁúȯÀÌ´Ù. °ü»ó µ¿¸ÆÀÇ Á×»ó °æÈ­¿¡ µû¸¥ Æó»öÀÌ ÁÖ¿ä º´ÀÎÀ̱⠶§¹®¿¡ Áß³â ÀÌÈÄÀÇ Æ¯È÷ ³²ÀÚ¿¡°Ô¼­ ¸¹ÀÌ º¼ ¼ö ÀÖ´Ù. °ü»ó µ¿¸ÆÀÇ ¿¬ÃàÀ̳ª Æó»öÀÌ ¿øÀÎÀÌ µÇ´Â ¼öµµ ÀÖ´Ù. ÀÓ»ó Áõ»óÀº Áö¼ÓÀûÀÌ°í ½ÉÇÑ Çù½ÉÁõ°ú °°Àº ÅëÁõ ¹ßÀÛÀ» ³ªÅ¸³»°í Ç÷¾ÐÀÌ Çϰ­ÇÏ°í ¶§·Î´Â ¼îÅ© »óŰ¡ µÇ´Â ¼öµµ Àִµ¥ °ÅÀÇ Áõ»óÀÌ ¾øÀÌ °æ°úÇÏ´Â ¼öµµ ÀÖ´Ù. 2. ½É±Ù ºÎÀ§ÀÇ ÇãÇ÷¼º ±«»çÀÌ´Ù. ½É±Ù °æ»öÁõÀº ÇãÇ÷¼º ½ÉÀå ÁúȯÀÇ Ãʱâ Áõ»óÀÏ ¼ö ÀÖÁö¸¸, ȯÀÚµéÀº ±Þ¼º ½É±Ù °æ»öÁõ Àü¿¡ Çù½ÉÁõÀ» °æÇèÇÏ°Ô µÈ´Ù. ½É±Ù °æ»öÁõÀÇ ÀÓ»óÀû ÇüÅ´ °æµµÀÇ °æ¿ìºÎÅÍ ÀϽÃÀû Çù½ÉÁõÀÇ Áõ»ó±îÁö ´Ù¾çÇѵ¥ ÀÌ·¯ÇÑ ÀϽÃÀûÀÎ Áõ»ó¿¡´Â ½É±Ù ±«»ç¸¦ ÀÏÀ¸Å°´Â °Í°ú °°Àº ½ÇÁ¦ÀûÀÎ Áø´ÜÀº ³»·ÁÁöÁö ¾Ê´Â´Ù. ´ÙÀ½°ú °°Àº 3°¡Áö ÈÄÀ¯ÁõÀÌ ¸ðµç ½É±Ù °æ»öÁõ ȯÀڵ鿡°Ô¼­ ³ªÅ¸³­´Ù. 1
  • myocardial irritability
    ½É±Ù °ú¹Î¼º, ½É±Ù ÀÚ±Ø ÈïºÐ¼º
  • myocardial lead
    ½É±Ù À¯µµ
  • myocardial necrosis
    ½É±Ù ±«»ç
  • myocardial primordium
    ½ÉÀå ±ÙÀ°Ãþ ¿ø±â
  • myocardial scan
    ½É±Ù ÁÖ»ç
  • myocardial stimulants
    ½É±Ù ÀÚ±ØÁ¦
  • air flow
    ±â·ù
  • aqueous flow
    ¹æ¼ö È帧, ¹æ¼ö·ù
  • blood flow pattern
    Ç÷·ù ¾ç»ó
  • blood flow velocity
    Ç÷·ù ¼Óµµ
  • bulk flow
    µ¢¾î¸® È帧
  • color Doppler flow mapping
    »ö µµÇ÷¯ Ç÷·ù ÁöµµÈ­
  • color flow imaging
    »öÇ÷·ù ¿µ»ó
  • continuous flow blood analysis
    Áö¼Ó¼º À¯µ¿ Ç÷¾× ºÐ¼®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
expiratory reserve volume The extra volume of air that can be expired with maximum effort beyond the level reached at the end of a normal, quiet expiration. Common abbreviation is erv.
(12 Dec 1998)
late-successional reserve An area of forest where the management objective is to protect and enhance conditions of late successional and old-growth forest ecosystems.
(05 Dec 1998)
anterior myocardial infarction Infarction involving the anterior wall of the heart, and producing indicative electrocardiographic changes in the anterior chest leads and often in limb lead I.
(05 Mar 2000)
anteroinferior myocardial infarction Infarction involving both anterior and inferior walls of the heart simultaneously.
(05 Mar 2000)
anterolateral myocardial infarction Extensive anterior infarction producing indicative changes across the precordium as well as in leads I and aVL.
(05 Mar 2000)
anteroseptal myocardial infarction An anterior infarction in which indicative electrocardiographic changes are confined to the medial chest leads (V1-V4).
(05 Mar 2000)
biopsy, myocardial <investigation, procedure, surgery> A procedure which involves the removal of a small specimen of cardiac muscle tissue for microscopic analysis.
This is generally performed at the same time as a cardiac catheterisation or as a very similar, yet separate, procedure. A small piece of heart tissue is taken via a small forceps inserted into the cardiac catheter site (usually threaded through a vein in the neck).
This test may reveal the cause of a cardiomyopathy, myocarditis, amyloidosis or a heart transplant rejection.
(21 Mar 1998)
myocardial Refers to the heart's muscle mass.
(09 Oct 1997)
myocardial biopsy <procedure> A procedure which involves the removal of a small specimen of cardiac muscle tissue for microscopic analysis.
This is generally performed at the same time as a cardiac catheterisation or as a very similar, yet separate, procedure. A small piece of heart tissue is taken via a small forceps inserted into the cardiac catheter site (usually threaded through a vein in the neck). This test may reveal the cause of a cardiomyopathy, myocarditis, amyloidosis or a heart transplant rejection.
(27 Sep 1997)
myocardial bridge A bridge of cardiac muscle fibres extending over the epicardial aspect of a coronary artery; this finding, in cases of sudden unexpected death, has led to speculation that cardiac contraction during exertion could constrict the coronary artery.
(05 Mar 2000)
myocardial contraction Contractile activity of the heart.
(12 Dec 1998)
myocardial contusion A bruise to the heart muscle, usually caused by a blunt force applied to the anterior thorax (motor vehicle accident). Commonly seen in association with a rib or sternum fracture. Complications include cardiac arrhythmias and death.
(27 Sep 1997)
myocardial depressant factor A low molecular weight peptide of about 800-1000 having a negative inotropic effect. It is released into the circulation during experimental haemorrhagic pancreatitis, severe ischemia, and postoligaemic shock.
(12 Dec 1998)
myocardial diseases Diseases of the myocardium.
(12 Dec 1998)
myocardial infarct imaging <radiology> Tc-99m pyrophosphate (PYP) 20 mCi, peak abnormality 2-3 days, often falsely negative before 2 days, abnormal for 7-10 days, mechanism: calcium influx into ischemic cells, PYP incorporated into crystalline structure, analogous to hydroxyapatite see: nuclear cardiology
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Federal Reserve Board
    ¿¬¹æÁغñ±¹
  • Federal Reserve System
    ¿¬¹æÁغñÁ¦µµ
  • Reserve Officers' Training Corps
    ¿¹ºñ¿ª Àå±³(Çеµ ±º»ç)ÈÆ·Ã´Ü
  • central reserve(reservation)
    MEDIAN STRIP
  • contingency reserve
    ¿ì¹ß ¼Õ½Ç(À§Çè)Áغñ±Ý
  • depreciation reserve
    °¨°¡ »ó°¢ Áغñ±Ý
  • foreign currency reserve
    ¿ÜÈ­ º¸À¯(°í)
  • foreign reserve
    ¿ÜÈ­ º¸À¯(°í)
  • foreign reserve
    ¿ÜÈ­ Áغñ(±Ý)
  • game reserve
    =game preserve
  • gold reserve
    Á¤È­Áغñ
  • hidden reserve
    Àº´Ð Àû¸³±Ý
  • inner reserve
    (´ëÂ÷ ´ëÁ¶Ç¥¿¡ ½ÆÁö ¾ÊÀº)³»ºÎ À¯º¸±Ý;ºñ¹Ð Àû¸³±Ý
  • legal reserve
    ¹ýÁ¤Áغñ±Ý
  • naval reserve
    (±º)ÇØ±º¿¹ºñ¿ª
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á